NCT02368743View on ClinicalTrials.gov

QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®)

CompletedOBSERVATIONAL
Enrollment

117

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

January 2, 2018

Conditions
Distal Ulcerative Colitis
Interventions
DRUG

mesalazine

Trial Locations (1)

Unknown

Gastro-Entérologie et Hépatologie - CHU Brabois (there may be other sites in this country), Vandœuvre-lès-Nancy

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY